Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older. This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions. Fintepla (fenfluramine) comes as an oral solution, so it's a good option for people who can't swallow pills.
Treatment of seizures caused by Dravet syndrome (DS)
Treatment of seizures caused by Lennox-Gastaut syndrome (LGS)
Fintepla (fenfluramine) is an antiepileptic. It's not entirely clear how this medication works to treat seizures. But it's thought to act on the serotonin system in your body, which might help you have fewer seizures.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Available in liquid form, which is helpful for people who can't swallow pills
Cherry flavored and doesn't contain any ingredients made from gluten-containing grain
Can give through gastric and nasogastric feeding tubes
Can use for children as young as 2 years old
Only for treatment of seizures caused by Dravet syndrome or Lennox-Gastaut syndrome
Only available as a brand medication, so there's no lower-cost generic available
Need to enroll in a special medication safety program in order to get it
You can take Fintepla (fenfluramine) with or without food. Food won't affect how this medication works in your body.
Fintepla (fenfluramine) can make you feel drowsy, tired, or weak. Avoid activities that require you to be alert, such as driving a car or operating machinery, until you know how the medication affects you. These effects usually get better over time.
Read the Instructions For Use that come with Fintepla (fenfluramine) on how to measure out your dose. If you have any concerns or questions about the instructions, contact your provider or pharmacist for help.
Measure your Fintepla (fenfluramine) dose using the oral dosing syringe that comes with the medication only. Don't use a regular household teaspoon or tablespoon to measure out your dose because they aren't accurate. You might accidentally take an incorrect amount of medication. This can raise your risk of seizures or side effects.
Rinse the oral syringe after each use with clean tap water and let it air dry. It's also safe to put the syringe in the dishwater to clean.
Don't stop taking Fintepla (fenfluramine) without speaking to your provider first. Stopping this medication suddenly can raise your risk of having seizures more often or seizures that don't stop. Contact your provider if you want to stop taking Fintepla (fenfluramine) so they can instruct you on how to do so safely.
Fintepla (fenfluramine) can lower your child's appetite, which can lead to weight loss. Your child's provider will track their growth closely during treatment. If you notice a change in your child's weight or appetite, let the provider know because they might prescribe a lower dose of medication.
Keep the Fintepla (fenfluramine) bottle and oral syringe at room temperature. Don't refrigerate or freeze it since this could damage the medication.
Throw away any medication that you haven't used 3 months after first opening the bottle. If the "Discard After" date on the bottle comes sooner than 3 months, follow the "Discard After" date and throw away any unused medication then.
Fintepla (fenfluramine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Taking certain medications that raise serotonin levels in the body, including Fintepla (fenfluramine) | History of valvular heart disease
Medications that work similarly to Fintepla (fenfluramine) might be linked to high blood pressure in the lungs (pulmonary hypertension) and damage to heart valves. Before you start this medication, your provider will check your heart and lungs with an imaging scan called an echocardiogram. You'll need to get imaging done every 6 months during treatment. Then, continue to get imaging every 3 to 6 months after finishing treatment with Fintepla (fenfluramine). Discuss options with your provider if you have a history of valvular heart disease or already have high blood pressure in your lungs.
Because of the risks of serious heart and lung problems, Fintepla (fenfluramine) is only available through a restricted distribution program called the Fintepla REMS program. You'll have to enroll in this program and follow its monitoring requirements. Your pharmacy must also register with this program, so you won't be able to fill your prescription at just any pharmacy.
Risk factors: Taking higher doses of Fintepla (fenfluramine)
Fintepla (fenfluramine) can lower your appetite, which can lead to weight loss. This effect seems to be related to the amount of medication you're taking. Talk with your provider if you notice that your appetite is lower than usual or that you're losing weight while taking this medication. You might need a lower dose of Fintepla (fenfluramine).
Antiepileptic (antiseizure) medications like Fintepla (fenfluramine) can raise your risk of suicide or thoughts of suicide. Watch for any new or worsening depression and any unusual changes in mood, especially during the first few months of taking this medication or if your dose changes. Report anything concerning to your provider. If you have thoughts of hurting yourself, call 911 or get medical attention right away.
Risk factors: Taking monoamine oxidase inhibitors (MAOI) 14 days before starting Fintepla (fenfluramine) | Taking other medications that raise serotonin levels in your brain
Serotonin syndrome is a rare but potentially life-threatening condition where there's too much serotonin in the brain. Serotonin is one of the chemicals in your brain responsible for your mood. Your risk for serotonin syndrome goes up if you use Fintepla (fenfluramine) with other medications that affect serotonin levels, such as certain antidepressants, MAOI medications like selegiline, lithium, and migraine medications called triptans. Make sure your provider knows about all the medications you take before starting Fintepla (fenfluramine). Don't start any new medications while taking Fintepla (fenfluramine) without letting your pharmacist or provider know. Symptoms of serotonin syndrome include fast heart rate, sweating, muscle stiffness or spasms, fever, and confusion. Get medical help right away if you have any of these symptoms.
Fintepla (fenfluramine) can raise your blood pressure, even in people who don't have high blood pressure. Your provider will check your blood pressure during treatment to make sure it stays in a healthy range.
Fintepla (fenfluramine) can cause your pupils to dilate (widen) and can even cause glaucoma (high pressure in the eye). Let your provider know if you have a history of eye problems. Also contact them if you start having vision changes or eye discomfort while taking this medication. You might need to stop Fintepla (fenfluramine) if you develop vision changes.
Your dose is based on your body weight. The typical starting dose is 0.1 mg/kg of body weight by mouth twice a day.
After a week, your or your child's provider will adjust the dose depending on how many seizures are still happening and the side effects you or your child might have. The maximum dose is 26 mg per day.
Your dose might differ if you have kidney or liver problems, or if you're also taking certain medications, including Diacomit (stiripentol) and clobazam (Onfi).
Currently take or have taken medications called monoamine oxidase inhibitors (MAOIs) within the last 14 days
Treatment of seizures caused by Dravet syndrome (DS)
Treatment of seizures caused by Lennox-Gastaut syndrome (LGS)
Seizures associated with Dravet syndrome in people 2 years and older who are also taking clobazam (Onfi)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (2019). Pulmonary hypertension.
Centers for Disease Control and Prevention. (2019). Valvular heart disease.
Centers for Disease Control and Prevention. (2020). Spoons are for soup, milliliters are for medicine.
Gilliam, F. G., et al. (2021). Serotonergic therapy in epilepsy. Current Opinion in Neurology.
MedlinePlus. (2022). Feeding tube insertion - gastrostomy.
MedlinePlus. (2022). Nasogastric feeding tube.
National Institute of Neurological Disorders and Stroke. (2023). Dravet syndrome.
National Institute of Neurological Disorders and Stroke. (2023). Lennox-Gastaut syndrome.
UCB, Inc. (n.d.). What is the Fintepla REMS (Risk Evaluation and Mitigation Strategy)?
UCB, Inc. (2023). Fintepla- fenfluramine solution [package insert]. DailyMed.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.